CRI Logo
  • About
    • Impact
    • History
    • Team
    • Careers
    • Blog
    • Media Room
  • What is Immunotherapy?
    • Immunotherapy Basics
    • Treatment Types
    • Cancer Types
    • Side Effects
  • Patient Support
    • Patient Resources
    • Clinical Trials
    • Immunotherapy Stories
    • Connect with ImmunoAdvocates
  • Grants & Research Programs
    • Apply for Grants
    • Research Programs
    • Clinical Programs
    • Data Programs
    • CRI Funded Scientists
  • Get Involved
    • Ways to give
    • Fundraise
    • Events
    • Partnership
    • Contact
Donate

Immune to Cancer: The CRI Blog

  • Dr. Ana Aparicio Answers Questions About Prostate Cancer and Immunotherapy After the 2021 CRI Virtual Immunotherapy Patient Summit

    Dr. Ana Aparicio, of The University of Texas MD Anderson Cancer Center, answers questions about prostate cancer…

    December 13, 2021| CRI Staff
  • Prostate Cancer Awareness Month: 2021 Immunotherapy Research Updates

    This September for Prostate Cancer Awareness Month, we examine promising new treatments, new research, and how we’re…

    September 2, 2021| Gabriella Rojas
  • John Yaryan

    John Yaryan’s Immunotherapy Story

    Prostate Cancer |  Diagnosed 2011 A lot of people are really hesitant to do these clinical trials, but…
    April 27, 2021| CRI Staff
  • Dr. Sumit Subudhi Answers Questions on Prostate Cancer and Immunotherapy from the CRI Virtual Immunotherapy Patient Summit

    Sumit K. Subudhi, MD, PhD, answers questions on immunotherapy for prostate cancer from the 2020 CRI Virtual Immunotherapy…

    November 12, 2020| CRI Staff
  • Prostate Cancer Awareness Month: 2020 Immunotherapy Research Updates

    This September for Prostate Cancer Awareness Month, we look at new treatment combinations, new research, and how…

    September 3, 2020| CRI Staff
  • Advances in Immunotherapy for Prostate Cancer with Dr. Sumit Subudhi

    For Prostate Cancer Awareness Month, CRI spoke with Dr. Sumit Subudhi about advances in immunotherapy for prostate…

    September 1, 2020| Arthur N. Brodsky, PhD
  • PORTER Immunotherapy Clinical Trial for Prostate Cancer Unveiled at SITC2019

    Details of a promising new CRI co-funded clinical trial for metastatic prostate cancer unveiled at the 2019…

    October 31, 2019| Arthur N. Brodsky, PhD
  • Prostate Cancer Awareness Month: 2019 Immunotherapy Research Update

    For Prostate Cancer Awareness Month, we round up the latest news and research from the people changing…

    September 11, 2019| CRI Staff
  • How Immunotherapy Is Making an Impact in Prostate Cancer

    We spoke with Sumit K. Subudhi, MD, PhD, about the current treatment landscape for patients with prostate…

    September 10, 2019| Arthur N. Brodsky, PhD
1 2
Next Page

Cancer Research Institute
29 Broadway, Floor 4

New York, NY  10006-3111

Facebook Icon
X icon
YouTube icon
LinkedIn icon
Instagram icon
Threads icon
  • About
    • Impact
    • History
    • Team
    • Careers
    • Blog
    • Media Room
  • What is Immunotherapy?
    • Immunotherapy Basics
    • Treatment Type
    • Cancer Type
    • Side Effects
  • Patient Support
    • Patient Resources
    • Clinical Trials
    • Immunotherapy Stories
    • Connect with ImmunoAdvocates
  • Grants & Research Programs
    • Apply for Grants
    • Research Programs
    • Clinical Programs
    • Data Programs
    • CRI Funded Scientists
  • Get Involved
    • Donate
    • Ways to give
    • Fundraise
    • Events
    • Partnership
    • Contact

Uniting for a World Immune to Cancer

  • Accessibility Statement
  • Privacy Policy
  • Terms & Conditions
  • Site Map

*Immunotherapy results may vary from patient to patient.

©2025, Cancer Research Institute